CD138 as a component of the endothelial glycocalyx has often been reported as a potential marker for the illness progression of COVID-19 patients (42).The expression of CD138 was measured in ECs treated for 24 h with medium, the severe cytokine cocktail in the absence or presence of 2h-treatment of FX06. Here, SDC1 is linked to COVID-19.